Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 658

1.

Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.

Toiyama Y, Takahashi M, Hur K, Nagasaka T, Tanaka K, Inoue Y, Kusunoki M, Boland CR, Goel A.

J Natl Cancer Inst. 2013 Jun 19;105(12):849-59. doi: 10.1093/jnci/djt101.

2.

Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.

Hur K, Toiyama Y, Schetter AJ, Okugawa Y, Harris CC, Boland CR, Goel A.

J Natl Cancer Inst. 2015 Feb 6;107(3). pii: dju492. doi: 10.1093/jnci/dju492.

3.

Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.

Toiyama Y, Hur K, Tanaka K, Inoue Y, Kusunoki M, Boland CR, Goel A.

Ann Surg. 2014 Apr;259(4):735-43. doi: 10.1097/SLA.0b013e3182a6909d.

4.

Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer.

Liu GH, Zhou ZG, Chen R, Wang MJ, Zhou B, Li Y, Sun XF.

Tumour Biol. 2013 Aug;34(4):2175-81. doi: 10.1007/s13277-013-0753-8.

PMID:
23625654
5.

Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.

Yuan D, Li K, Zhu K, Yan R, Dang C.

Cancer Biol Ther. 2015;16(2):268-75. doi: 10.1080/15384047.2014.1002327.

6.

MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer.

Yau TO, Wu CW, Tang CM, Chen Y, Fang J, Dong Y, Liang Q, Ng SS, Chan FK, Sung JJ, Yu J.

Oncotarget. 2016 Jan 12;7(2):1559-68. doi: 10.18632/oncotarget.6403.

7.

Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.

Imaoka H, Toiyama Y, Fujikawa H, Hiro J, Saigusa S, Tanaka K, Inoue Y, Mohri Y, Mori T, Kato T, Toden S, Goel A, Kusunoki M.

Ann Oncol. 2016 Oct;27(10):1879-86. doi: 10.1093/annonc/mdw279.

PMID:
27502702
8.

A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.

Kanaan Z, Roberts H, Eichenberger MR, Billeter A, Ocheretner G, Pan J, Rai SN, Jorden J, Williford A, Galandiuk S.

Ann Surg. 2013 Sep;258(3):400-8. doi: 10.1097/SLA.0b013e3182a15bcc.

PMID:
24022433
9.

Prognostic implications of serum microRNA-21 in colorectal cancer.

Menéndez P, Padilla D, Villarejo P, Palomino T, Nieto P, Menéndez JM, Rodríguez-Montes JA.

J Surg Oncol. 2013 Nov;108(6):369-73. doi: 10.1002/jso.23415.

PMID:
23970420
10.

Prognostic significance of microRNA-16 expression in human colorectal cancer.

Qian J, Jiang B, Li M, Chen J, Fang M.

World J Surg. 2013 Dec;37(12):2944-9. doi: 10.1007/s00268-013-2205-4.

PMID:
24045965
11.

Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.

Wang LL, Du LT, Li J, Liu YM, Qu AL, Yang YM, Zhang X, Zheng GX, Wang CX.

World J Gastroenterol. 2014 Aug 28;20(32):11340-6. doi: 10.3748/wjg.v20.i32.11340.

12.

The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.

Chen WY, Zhao XJ, Yu ZF, Hu FL, Liu YP, Cui BB, Dong XS, Zhao YS.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):7092-101.

13.

Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.

Lv ZC, Fan YS, Chen HB, Zhao DW.

Tumour Biol. 2015 Mar;36(3):1619-25. doi: 10.1007/s13277-014-2760-9.

PMID:
25528214
14.

Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma.

Wu CW, Ng SC, Dong Y, Tian L, Ng SS, Leung WW, Law WT, Yau TO, Chan FK, Sung JJ, Yu J.

Clin Cancer Res. 2014 Jun 1;20(11):2994-3002. doi: 10.1158/1078-0432.CCR-13-1750.

15.

Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.

Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X.

Int J Cancer. 2010 Jul 1;127(1):118-26. doi: 10.1002/ijc.25007.

16.

Serum miR-372 is a Diagnostic and Prognostic Biomarker in Patients with Early Colorectal Cancer.

Yu J, Jin L, Jiang L, Gao L, Zhou J, Hu Y, Li W, Zhi Q, Zhu X.

Anticancer Agents Med Chem. 2016;16(4):424-31.

PMID:
26179262
17.

The relationship between and clinical significance of MicroRNA-32 and phosphatase and tensin homologue expression in colorectal cancer.

Wu W, Yang P, Feng X, Wang H, Qiu Y, Tian T, He Y, Yu C, Yang J, Ye S, Zhou Y.

Genes Chromosomes Cancer. 2013 Dec;52(12):1133-40. doi: 10.1002/gcc.22108.

PMID:
24123284
18.

Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer.

Lin Q, Chen T, Lin Q, Lin G, Lin J, Chen G, Guo L.

J Surg Oncol. 2013 Jun;107(7):767-71. doi: 10.1002/jso.23312.

PMID:
23609137
19.

Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma.

Li J, Liu Y, Wang C, Deng T, Liang H, Wang Y, Huang D, Fan Q, Wang X, Ning T, Liu R, Zhang CY, Zen K, Chen X, Ba Y.

Sci Rep. 2015 Aug 7;5:12921. doi: 10.1038/srep12921.

20.

N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.

Melotte V, Lentjes MH, van den Bosch SM, Hellebrekers DM, de Hoon JP, Wouters KA, Daenen KL, Partouns-Hendriks IE, Stessels F, Louwagie J, Smits KM, Weijenberg MP, Sanduleanu S, Khalid-de Bakker CA, Oort FA, Meijer GA, Jonkers DM, Herman JG, de Bruïne AP, van Engeland M.

J Natl Cancer Inst. 2009 Jul 1;101(13):916-27. doi: 10.1093/jnci/djp131.

Items per page

Supplemental Content

Support Center